Alternaria Alternata (Alt a 1) IgE

If you wheeze in late summer, your asthma flares when you cut the grass, or your nose runs after a damp basement visit, the culprit is often a mold called Alternaria alternata. This test pinpoints whether your immune system is reacting to its main allergy-triggering protein, called Alt a 1 (Alternaria alternata allergen 1).

Most generic mold tests measure a crude mix of fungal proteins, which can produce confusing or cross-reactive results. Targeting the single most important Alternaria protein gives you a sharper, more reliable answer about whether this specific mold is driving your symptoms and whether you might benefit from allergy shots aimed at it.

What This Test Actually Measures

Alt a 1 (Alternaria alternata allergen 1) is a small protein associated with Alternaria spores. When your immune system mistakes it for a threat, it makes a specific antibody called IgE (immunoglobulin E, the class of antibodies that drives classic allergy). This blood test counts how much of that anti-Alt a 1 IgE you have circulating.

Among people with clinically confirmed Alternaria allergy, the great majority carry IgE to Alt a 1, which is why it is called the major Alternaria allergen. In one study, 98% of Alternaria-allergic adults had IgE to Alt a 1 alone, enough for a reliable diagnosis without needing to test other Alternaria proteins. In broader populations that test positive on whole-extract Alternaria panels, the share with Alt a 1 IgE can be lower (around 50 to 60% in some cohorts), since some of those positives reflect cross-reactivity rather than true Alternaria allergy.

Asthma and the Mold Connection

Alternaria sensitization is one of the strongest mold-related risk factors for asthma. Among asthmatic and rhinitis patients with high Alternaria reactivity on standard testing, 93% had IgE to Alt a 1, marking it as a reliable signal of genuine sensitization rather than a fluke.

In a study of 582 asthmatic patients, those sensitized to Alternaria tended to be younger and male, with higher total IgE and more polysensitization (allergies to multiple things at once). In a population-based survey of more than 8,000 people, having mold-specific IgE independently raised the odds of reporting allergy symptoms, even after accounting for other allergies.

Allergic Rhinitis and Rhinoconjunctivitis

Allergic rhinitis driven by Alternaria shows up as seasonal congestion, sneezing, and itchy eyes, often peaking in late summer and fall when spore counts climb. In children and adults with rhinoconjunctivitis, a positive Alt a 1 IgE result identifies who is likely to benefit from Alternaria-specific allergy shots.

A randomized, placebo-controlled trial of allergy shots using purified Alt a 1 cut symptom and medication scores within a year. A pilot study in 42 children with allergic rhinitis showed that polymerized Alt a 1 shots reduced Alt a 1-specific IgE from 28.6 to 19.5 kUA/L (kilounits of allergen-specific IgE per liter, a roughly 32% drop) over two years, alongside better nasal airflow.

Chronic Sinus Disease and Nasal Polyps

Early research in chronic rhinosinusitis with nasal polyps suggests that the amount of Alt a 1 found inside polyp tissue tracks with local Alternaria-specific IgE, the inflammatory signals IL-4 and IL-33 (immune messengers that drive allergy and eosinophil activity), and the risk that polyps will come back after surgery.

If your blood test shows high Alt a 1 IgE and you have recurrent polyps or stubborn sinus disease, mold may be playing a larger role in your inflammation than a generic workup would suggest.

Atopic Dermatitis: A More Nuanced Picture

People with moderate-to-severe atopic dermatitis often have positive standard Alternaria blood tests, but many of them have low or absent IgE to Alt a 1 specifically. This pattern suggests their reactivity comes from other fungal proteins or nonspecific antibody binding rather than true Alternaria allergy.

This is one of the clearest reasons to ask for component-level testing rather than relying on whole-extract mold panels: it separates genuine Alternaria-driven disease from background atopy, which changes whether allergy shots make sense.

When a Single Reading Can Mislead You

A positive Alt a 1 IgE result confirms sensitization, not necessarily symptomatic allergy. Many people carry allergy antibodies without ever feeling symptoms, so your level only becomes meaningful when paired with a real-world reaction pattern (sneezing in damp environments, asthma flares in late summer, eyes itching after yardwork).

A negative result mostly rules out Alternaria allergy, but not entirely. Roughly 2% of Alternaria-sensitized people react to other Alternaria proteins rather than Alt a 1. If your symptoms strongly point to mold and your Alt a 1 IgE is negative, a whole-extract Alternaria test may catch what the component test missed.

Different lab platforms (ImmunoCAP, ALEX2, and others) correlate well but are not identical. Sticking with one lab and one method makes serial comparisons more meaningful.

Tracking Your Trend Over Time

A single Alt a 1 IgE reading tells you whether you are sensitized today. The bigger value comes from tracking how that number moves: it tends to stay stable when you are not being treated, drift down as you age out of a childhood allergy, or fall meaningfully if you start Alternaria-specific allergy shots.

A reasonable cadence is a baseline test when symptoms suggest mold allergy, a recheck after 6 to 12 months if you change your environment or start treatment, and then annually if you are on immunotherapy or your symptoms are still active. A falling number combined with fewer symptoms is one of the clearest signals that treatment is working.

What to Do If Your Result Is Elevated

An out-of-pattern result is most useful when paired with the right next steps rather than a panic-driven retest. If your Alt a 1 IgE is elevated and your symptoms fit, the productive workup usually involves a few combinations of findings rather than a single number.

• Pair with whole-extract Alternaria IgE and total IgE: this confirms genuine sensitization and characterizes your overall atopic load.
• Add component testing for other mold and inhalant allergens: many people sensitized to Alternaria are polysensitized; mapping the full pattern changes treatment.
• Consider a skin prick test or nasal/bronchial provocation through an allergist: especially important before starting allergen-specific immunotherapy, since correlation between blood IgE and provoked symptoms is only moderate in children.
• Evaluate for nasal polyps or chronic sinus inflammation if symptoms fit: an ENT specialist can assess local Alternaria-related inflammation that blood tests cannot see.

If your Alt a 1 IgE is high but your symptoms are minimal, the result is still useful as a baseline. It tells you which environmental triggers to watch and gives you a comparison point if airway or sinus symptoms develop later.